학술논문
Patients with cardiac implantable electronic devices undergoing radiotherapy in Poland. Expert opinion of the Heart Rhythm Section of the Polish Cardiac Society and the Polish Society of Radiation Oncology.
Document Type
Academic Journal
Author
Tajstra M; 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. Electronic address: mateusztajstra@wp.pl; Blamek S; Department of Radiotherapy, Maria Sklodowska-Curie Institute — Oncology Center, Gliwice Branch, Gliwice, Poland; Niedziela JT; 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland; Gadula-Gacek E; 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland; Przybylski A; Faculty of Medicine, University of Rzeszów, Poland; Blicharz J; Department of Cardiology, St.Luke’s Voivoideship Hospital,Tarnów, Poland; Oręziak A; Department of Arrhythmia, Institute of Cardiology, Warsaw, Poland; Miszczyk L; Department of Radiotherapy, Maria Sklodowska-Curie Institute — Oncology Center, Gliwice Branch, Gliwice, Poland; Gepner K; Department of Oncology Diagnostics, Cardiooncology and Palliative Medicine, Maria Sklodowska-Curie Institute — Oncology Center, Warsaw, Poland; Fijuth J; Department of Radiotherapy, Medical University ofLodz, Łódź, Poland; Department of Teleradiotherapy, Regional Cancer Center, Copernicus Memorial Hospital of Łódź, Poland; Składowski K; 1st Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie Institute — Oncology Center, Gliwice Branch, Gliwice, Poland; Leszek P; Department of HeartFailure and Transplantology, Institute of Cardiology, Warsaw, Poland; Kempa M; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Gdańsk, Poland; Kowalski O; Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Diseases, Zabrze, Poland; Department of Dietetics, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland; Sterliński M; Department of Arrhythmia, Institute of Cardiology, Warsaw, Poland
Source
Publisher: Via Medica Country of Publication: Poland NLM ID: 0376352 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1897-4279 (Electronic) Linking ISSN: 00229032 NLM ISO Abbreviation: Kardiol Pol Subsets: MEDLINE
Subject
Language
English
Abstract
Older age and high morbidity of the society contribute to a growing number of patients with cardiac implantable electronic devices (CIEDs) requiring effective cancer treatment, including radiotherapy (RT). The effect of RT on a CIED may vary depending on the type and physical parameters of radiation, location of the treated lesion, indications for electrotherapy, and the type of CIED. In the most dramatic scenarios, it may cause an irreversible damage to the CIED, with serious clinical consequences. The lack of precise guidelines may limit the access to RT for many patients with CIEDs who would otherwise benefit from the therapy or may lead to a therapy without taking the necessary precautions, which may worsen the prognosis. Therefore, clear and unequivocal recommendations for assessing patient eligibility for RT are aimed at ensuring that adequate precautions are taken as well as at providing patients with concomitant cardiovascular and oncologic diseases with access to safe and effective RT.